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Cystic fibrosis (CF) is the most common Caucasian autosomal recessive disease. It is due to mutations in the cystic fibrosis transmembrane
conductance regulator (CFTR) gene encoding the CFTR protein, which is a chloride (Cl−) channel. The most common mutation leads to a missing
phenylalanine at position 508 (ΔF508). The ΔF508-CFTR protein is misfolded and retained in the endoplasmic reticulum and may trigger the
unfolded protein response (UPR). Furthermore, CF is accompanied by inflammation and infection, which are also involved in the UPR. To date,
the UPR transducer ATF6 and ER stress sensor Grp78 have been used as UPR markers. Therefore, our aim was to study the activation of ATF6
and Grp78 in transfected human epithelial cells expressing the ΔF508-CFTR protein, and we showed that they are activated in these cells. We
investigated the effect of exogenous UPR inducers thapsigargin (Tg) and tunicamycin (Tu) on Grp78 and ATF6 expression. Whereas the cells
reacted to the UPR induction, we show a difference in the electrophoretic pattern of ATF6. The Grp78/ATF6 complex was previously described,
but its stability during UPR is controversial. Using co-immunoprecipitation we show that it is stable in ΔF508-CFTR-expressing cells and is
maintained under UPR conditions. Finally, using siRNA, we show that decreased ATF6 expression induces increased cAMP-dependent halide
flux through ΔF508-CFTR due to its increased membrane localization. Therefore, our results suggest that UPR may be triggered in CF and that
ATF6 may be a therapeutic target.
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Cystic fibrosis (CF) is the most common lethal autosomal
recessive disease in the Caucasian population, and is due to
mutations in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene [1–3]. The normal CTR protein, which is
a member of the ATP-binding cassette transporters, functions as
a chloride (Cl−) channel [2,4,5]. It comprises two hydrophobicAbbreviations: CFTR, cystic fibrosis transmembrane conductance regulator;
NBD, nucleotide-binding domain; ER, endoplasmic reticulum; ATF6, activating
transporting factor 6; Grp78, glucose-regulated protein 78; Tg, thapsigargin; Tu,
tunicamycin
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ATP-binding activity [5], and a regulatory domain. In CF, the
gene encoding the CFTR protein is mutated, leading to an altered
protein processing or expression. Therefore, altered chloride
channel function through CFTR is the hallmark of CF. Never-
theless, the link between genotype and phenotype remains
unclear in CF.
The most common mutation in CF is a missing phenylalanine
at position 508 (ΔF508), which occurs in the first nucleotide-
binding domain (NBD1) of the CFTR protein. The pathology
associated with ΔF508-CFTR is believed to be a failure of the
mutated protein to traffic correctly to the plasma membrane
[6–9]. The ΔF508-CFTR protein is misfolded and is degraded
by proteasomes after becoming a substrate for the Hsc70-CHIP
E3 ubiquitin ligase [9–13]. Nevertheless, partial endoplasmic
reticulum (ER) retention of ΔF508-CFTR was reported in
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mutated CFTR protein is incompletely glycosylated and ac-
cumulates in the ER [6], and in pancreatic adenocarcinoma
cells, which naturally express the ΔF508 mutated protein, and
in the ER compartment [14]. Therefore, the misfolded CFTR is
likely partially targeted to degradation. Interestingly, some
studies indicate that theΔF508-CFTR protein can function as a
cAMP-dependent Cl− channel, suggesting that if conditions
could be created to allow the ΔF508-CFTR protein to exit the
ER and reach the membrane, it might partially correct the CF
defect.
Besides the accumulation of ΔF508-CFTR protein in the ER,
inflammation and infection are the major features of CF [15].
Inflammation during CF produces local tissue damaging and
cytokines are found to be increased [16]. This inflammation pre-
cedes the numerous infections due to specific micro-organisms
such as Pseudomonas aeruginosa, Staphylococcus aureus, Bur-
kholderia cepacia and Haemophilus influenza [17–19]. The
consequence is an increased endobronchial inflammatory re-
sponse [20]. Viral infections are also found during CF (13–52%
of patients have a viral infection) with a worse prognosis than in
normal patients [21–29].
Eukaryotic cells respond to the stress due to the accumula-
tion of misfolded and unfolded proteins in the ER by activating
a signalling pathway known as the unfolded protein response
(UPR). Besides the accumulation of unfolded proteins in the
ER, a link between inflammation, infection and the UPR path-
way has been demonstrated in several models [30–32]. Because
both inflammation and retention of misfolded protein are ob-
served in CF, we hypothesized that UPR may be involved in CF.
The UPR induces the transcription of genes encoding the ER
chaperones, the protein-folding enzymes, the membrane traf-
ficking factors and components of the ER-associated degra-
dation system, limiting new protein synthesis [33–37]. Whereas
the UPR pathway is an adaptive process involved in restoration
of ER homeostasis, it may also lead to apoptotic cell death [38].
To date, the UPR transducer ATF6 (activating transcription fac-
tor 6) and ER stress sensor Grp78 (glucose-regulated protein
78)/BiP have been used as UPR markers [39–44]. ATF6 is a
bZIP transcription factor synthesized as an ER membrane pre-
cursor (90 kDa) with its C-terminus located in the ER lumen and
its N-terminal DNA-binding domain facing the cytosol [41].
During the UPR process, ATF6 is cleaved in the Golgi by site-1
and site-2 proteases as an active form (50 kDa) whichmigrates to
the nucleus of the stressed cells, where it acts as an activation
factor, binding and activating the ER stress response element
[40,41]. Grp78 (BiP, 78 kDa), which is a peptide-dependent
ATPase of the heat shock protein family, binds transiently to the
newly synthesized proteins translocated into the ER. Grp78 is
activated during the UPR process, which induces its redistribu-
tion from the ER lumen to the ER membrane [41]. Grp78 binds
to the hydrophobic exposed patches on the surface of the un-
folded proteins and is involved in the ATF6 activation due to
their association and dissociation [43,44]. IRE1 and PERK are
also known as UPR transducers [39,43]. They are both ER-
resident transmembrane proteins which are bound to Grp78.
Under UPR conditions they are released from Grp78 andactivated. Through its interactions with ATF6, IRE1 and PERK,
Grp78 is seen as the UPR sensor [43].
Our aim was first to study the activation of ATF6 and Grp78
in transfected human epithelial cells (A549 cells) expressing the
mutated CFTR protein. We showed for the first time that the
protein levels of ATF6 (active form) and Grp78 were increased
in the ΔF508-CFTR protein-expressing cells. Because addi-
tional stress such as inflammation and infection, which are
known to induce UPR, occur in CF, we investigated the effect of
exogenous UPR inducers. The depletion of ER calcium (Ca2+)
stores using thapsigargin (Tg) and the effect of the blockage
of N-linked protein glycosylation using tunicamycin (Tu) upon
Grp78 and ATF6 expression were studied in ΔF508-CFTR
protein-expressing cells. Whereas both cell lines react to UPR
induction, we show a difference in the electrophoretic pattern
of ATF6 in the ΔF508-CFTR-expressing cells under Tg or Tu
treatment. The Grp78/ATF6 complex was previously described
and, using co-immunoprecipitation, we show that it is stable
in ΔF508-CFTR-expressing cells and is maintained under UPR
conditions. Finally, using siRNA, we show that decreased ATF6
expression induces increased cAMP-dependent halide flux
throughΔF508-CFTR, whereas Grp78 has no effect. Therefore,
the present results suggest that ATF6 may be a therapeutic target
in CF.
2. Materials and methods
2.1. Antibodies and drugs
Polyclonal anti-Grp78 (H-129): sc-13968 antibody, monoclonal anti-ATF6
antibody (clone 70B1413) and monoclonal anti-CFTR antibody (MM13-4) were
from Santa Cruz Biotechnology, Stratagene and Interchim, respectively.
Secondary antibodies and the ECL+detection kit were from Amersham. The
siRNA directed against Grp78 and ATF6 (human, sc-29338 and sc-37699, re-
spectively; Santa Cruz Biotechnology), their negative control (scrambled
siRNA) and the transfection buffer were all from Tebu-Bio. Tu (T7765), Tg
(T9033), leupeptin, aprotinin, PMSF, iodoacetamide, pepstatin andDIFPwere all
from Sigma. The ER detection kit (SelectFX Alexa Fluor 488 ER labelling kit)
and the 6-methoxy-N-(3-sulfopropyl)quinolinium (SPQ) were from Molecular
Probes.
2.2. Cell culture conditions, plasmids and transfection
A549 cells, an alveolar type II epithelium-like cell line (ATCC, Rockville,
USA), were cultured in Ham's F-12 medium, as modified by M.E. Kaighn, and
supplemented with 10% foetal calf serum, 50 mg/ml streptomycin and 50 U/ml
penicillin in a 5% CO2-balanced air incubator at 37 °C.
The wild type human CFTR (Wt-CFTR) cDNA (4.5 kb) inserted in the
pTG5985 vector was tested by Western blotting and provided by Transgene
(Starsbourg, France). The cDNA (access Genbank no. M28668) was inserted in
pcDNA3.1 plasmid (InVitrogen) between the KpnI and XhoI restriction sites.
The cDNA encoding the ΔF508-CFTR protein was obtained by the use of
QuickChange II XL Site-Directed Mutagenesis Kit (Stratagene) according to the
manufacturer's instructions. The primers were: 5′-CTGGCACCATTAAA-
GAAAATATCATTGGTGTTTCCTATGATG-3′ (sense) and 5′-CATCATAG-
GAAACACCAATGATATTTTCTTTAATGGTGCCAG-3′ (antisense). In order
to assess the mutated cDNA, it was sequenced using the ABI PRISM 310
sequencing system (Applied Biosystems). A549 cells were transfected using
lipofectamine 2000 (Life Technologies) according to the manufacturer's
instructions, and stably transfected clones for normal and mutated construction
were isolated by neomycin selection. Surviving individual colonies were
inoculated, proliferated in the selective medium and used after 10 passages. To
induce UPR stress, cells were cultured for 24 h in the presence of Tu (10 μg/ml)
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blue exclusion test (not shown).
2.3. Immunofluorescence
Stably transfected A549 cells expressing human Wt-CFTR and ΔF508-
CFTR protein were grown on coverslips. The ER compartment was visualized
using the SelectFX Alexa Fluor 488 Endoplasmic Reticulum Labelling Kit
(S34200, Molecular Probes), according to the manufacturer's instructions. The
kit contains the cell fixation and permeabilisation buffers. Cells were further
incubated with the monoclonal anti-CFTR antibodies (1/10). After washing in
PBS, the cells were incubated with secondary anti-mouse FITC-linked anti-
bodies (1/100, Sigma) and the nuclei were stained with DAPI. First or secondary
antibodies were omitted from controls.
2.4. Protein extraction and Western blotting
Cell lysates were prepared from transfected A549 cells by resuspending the
cells on the plate in the lysis buffer (50 mM Tris–HCl, 100 mMNaCl, 1% Triton
X-100 [for co-immunoprecipitation] or 0.1% SDS [for Western blotting]), in the
presence of 1.1 μM leupeptin, 0.7 μM aprotinin, 120 μM PMSF, 1 μM iodo-
acetamide, 0.7 μMpepstatin and 1 mMDIFP. For nuclear preparation, cells were
washed with cold PBS and homogenized in NP-40 buffer. They were centrifuged
(1500 ×g, 10 min) and the supernatants were removed. The pellets were
homogenized in CaCl2 buffer and centrifuged (1500 ×g, 10 min). The super-
natants were discarded and the resuspended pellet was centrifuged (25,000 ×g,
for 30 min). Finally, the pellet (nuclear envelope) was homogenized. Protein
concentrations were determined by the method of Lowry et al., using bovine
serum albumin as standard [45]. Equal amounts of total proteins for each sample
were subjected to 10% or to 6% SDS/PAGE. After blotting, the membranes were
incubated with either anti-GRP78 (1/200) or anti-ATF6 (1/200) antibodies and
with the corresponding secondary antibodies. Visualization was performed using
an ECL+detection kit. Densitometric analysis of the signals was performed
using a GelDoc 2000 apparatus (Bio-Rad, France) and each value was
normalized to the total amount of loaded proteins per lane, which was estimated
after Coomassie blue staining of the membranes and densitometric analysis.
2.5. Cell surface expression of CFTR by biotinylation
The presence of the CFTR protein in the plasma membranes of the non-
transfected cells, in the Wt-CFTR-expressing cells and in the ΔF508-CFTR-
expressing cells was assessed. The proteins of the cell surface were biotinylated
as previously described [46]. Four T75 cm2 flasks of confluent cells were
washed with ice-cold PBS (pH 8.0) and the cells were incubated in Sulfo-NHS-
SS-Biotin solution (Pinpoint™ Cell Surface Protein Isolation Kit, Pierce, USA)
for 30 min at 4 °C. Cells were scraped and centrifuged for 3 min at 500 ×g. The
pellet was suspended in lysis buffer (50 mM Tris–HCl pH 6.8; 100 mM NaCl;
2% Triton X-100 and antiprotease cocktail) and incubated for 30 min on ice. The
cell lysates were clarified (10,000 ×g for 2 min at 4 °C) and biotinylated proteins
were isolated on Immobilized NeutrAvidin™ Gel (Pierce, USA). The CFTR
protein was further detected by Western blotting as described above.
2.6. Co-immunoprecipitation
Cells expressing normal or mutated CFTR, with and without Tg or Tu
incubation, were homogenized in Triton buffer and co-immunoprecipitations
were carried out with Dynabeads (Dynal Biotech) on which anti-Grp78 or anti-
ATF6 antibodies (2 μg per 100 μg of total protein) were linked, according to the
manufacturer's instructions. The beads were extensively washed and the im-
munoprecipitates were resolved by Western blot, and ATF6 or Grp78 was
detected. The amount of protein in the immunoprecipitates was assessed by
Coomassie blue staining of the membranes, in order to ensure that similar
amounts were loaded in each lane. Controls with an irrelevant antibody linked to
the beads and without primary or secondary antibody for detection were
negative. Positive controls were performed by the use of beads to which anti-
Grp78 or anti-ATF6 antibodies were linked when Grp78 or ATF6 was detected,
respectively.2.7. RNA interference
In cells expressing Wt-CFTR or ΔF508-CFTR protein, Grp78 and ATF6
inhibitions were performed using commercially available siRNA kits, in which
the siRNAs are target-specific, designed to knockdown the gene expression. The
minimal levels of Grp78 and ATF6 were assessed by Western blotting, as
described above, after different post-transfection times (24, 48 and 72 h). For
each siRNA experiment, negative controls were performed using the irrelevant
siRNA provided in the siRNA kits and using the siRNA buffers. The irrelevant
siRNAwas a scrambled sequence which did not lead to the specific degradation
of any cellular mRNA (Santa Cruz Biotechnology).
2.8. Methoxy-N-(3-sulfopropyl)quinolinium (SPQ) fluorescence assay
Stably transfected A549 cells with either the cDNA encoding the Wt-CFTR
or the cDNA encoding theΔF508-CFTR protein were used in SPQ experiments
as previously described, using forskolin as CFTR activator because it induces
cAMP synthesis which regulates the CFTR chloride channel function [47].
Cells were loaded with intracellular SPQ dye by incubation in Ca2+-free
hypotonic (50% dilution) medium containing 10 mM SPQ, 15 min, at 37 °C.
Coverslips were mounted on the stage of an inverted microscope equipped for
fluorescence and illuminated at 360 nm. The emitted light was collected at 456±
33 nm by a high-resolution image intensifier coupled to a video camera connected
to a digital image processing board controlled by FLUO software (Imstar, France).
Cells were maintained at 37 °C and continuously superfused with an extracellular
solution containing in mM: 145 NaCl, 4 KCl, 1 MgCl2, 1 CaCl2, 5 HEPES and
5 glucose, pH 7.4. A microperfusion system allowed local application and rapid
change of the different experimental mediums. Media containing iodide (I−) and
nitrate (NO3
−) were identical to the extracellular solution except that I− and NO3
−
replaced Cl− as the dominant extracellular anions. All extracellular media also
contained 10 μM bumetanide to inhibit the Cl−/Na+/K+ co-transporter. Single-cell
fluorescence intensity was measured from digital image processing and displayed
against time. Fluorescence intensity was standardized according to the equation
F=(F−F0) /F0×100, where F is the relative fluorescence and F0, the fluorescence
intensity measured in the presence of I−. Membrane permeability (p) to halides was
determined as the rate of SPQ dequenching upon perfusion with nitrates. At least
three successive data points were collected immediately after application of
the NO3
− containing medium, and then fitted using a linear regression analysis.
The slope of the straight line reflects the membrane permeability to halides (p in
min−1) and was used as an index of CFTR activity [47].
2.9. Statistics
Results were obtained from at least 10 different experiments and were
expressed as mean±standard error of the mean. Differences between experimental
groups were evaluated by a two-tailed unpaired Student's t test. pb0.05 was
considered significant (⁎) and pb0.001 was considered very significant (⁎⁎).
3. Results
3.1. Localization and cAMP-dependent halide flux through
Wt-CFTR and ΔF508-CFTR protein in the non-transfected and
in the stably transfected A549 cells
Two A549 cell lines were generated in order to express Wt-
CFTR or ΔF508-CFTR protein. Because the present study is
based onΔF508-CFTR protein retention in the ER, we assessed
the localization of the CFTR protein in both cell lines using
immunofluorescence. Wt-CFTR and ΔF508-CFTR were la-
belled, as well as the ER compartment. The nuclei were DAPI-
stained. We observed Wt-CFTR protein in the membranes (not
shown). The ΔF508-CFTR protein was mostly present in the
ER, around the nuclei. The controls performed without the first
or second antibody were negative. In the biochemical assay,
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A549 cells were purified and the CFTR protein was detected
using Western blotting. As shown in Fig. 1A, the CFTR protein
was present in the membrane of Wt-CFTR-transfected cells and
at a lower level in theΔF508-CFTR-expressing cells. No CFTR
protein was detected in the membrane of the native A549 cells.
The cAMP-dependent halide flux through CFTR was studied
in both cell lines using SPQ experiments, and non-transfected
cells were used as the control. As shown in Fig. 1B, the Wt-
CFTR-expressing cells exhibited cAMP-dependent halide flux,
whereas cells that were not transfected exhibited minimal fluo-
rescence. TheΔF508-CFTR-expressing cells exhibited a cAMP-
dependent halide flux which was reduced by nearly one-third
compared with that of the Wt-CFTR-expressing cells. Although
decreased, this functional activity inΔF508-CFTR cells has been
described before [46,48].
3.2. Comparison of the protein expression of Grp78 and ATF6
between the CFTR- and ΔF508-CFTR protein-expressing A549
cells
A large amount of work has established that specific induction
of Grp78 is indicative of ER stress (for review see [43]). There-
fore, we studied Grp78 protein expression in ΔF508-CFTR
protein-expressing cells and compared the results with the levelsFig. 1. Membrane localization and cAMP-dependent halide flux in non-transfected an
was detected byWestern blotting (7.5% gel electrophoresis). Whereas the CFTR prote
lower in the ΔF508-CFTR-expressing cells. No CFTR protein was detected in the n
CFTR stably expressing A549, ΔF508-CFTR-expressing and control cells. Data rep
selected cells, where F is the observed SPQ fluorescence and F0 the fluorescence in t
of 135 mM NaNO3, 1 mM Ca2SO4, 2.4 mM K2HPO4, 0.6 mM KH2PO4, 10 mM HE
measured after substitution of nitrate for I−. Cells were stimulated with forskolin (20 μ
I−-containing buffer (NaI, 150 mM) to obtain the minimum fluorescence. Each cur
fluorescence was observed in cells expressing CFTR protein (upper curve). In cells
fluorescence was residual in cells which did not express CFTR protein (not transfec
dequenching in NO3
−medium under baseline conditions (pbaseline) and under cAMP st
rate of SPQ dequenching presented in Figs. 7, 8 and 9. The slopes of the two line
conditions (pbaseline, a) and under cAMP stimulation (pcAMP, b). Data are the meansobserved in Wt-CFTR-expressing cells. Western blots were per-
formed on whole cell lysates as described elsewhere [43]. As
shown in Fig. 2A, the level of Grp78 was increased in ΔF508-
CFTR-expressing cells. Quantitative analysis of the signal (n=12)
indicated that the observed over-expression of Grp78 protein in
ΔF508-CFTR was significant (Fig. 2B).
Besides Grp78, ATF6 is a widely used UPR marker (for
review [49]). Therefore we studied its expression in both cell
lines. ATF6 has an electrophoretic mobility of 90 kDa and is
cleaved during UPR to an active fragment (50 kDa) [50]. As
shown in Fig. 2A, the cleaved fragment was observed in the
ΔF508-CFTR-expressing cells. Quantitative analysis of ATF6
(90 kDa form) clearly indicated its significantly increased
expression in ΔF508-CFTR protein-expressing cells (Fig. 2B).
Surprisingly, an additional band was observed in the 90 kDa
form of ATF6 in both cell lines (Fig. 2A). This additional band
was closer to the 90 kDa form of ATF6 in Wt-CFTR-expressing
cells than in theΔF508-CFTR protein-expressing cells. Such an
additional band was previously reported and was referred to as
the under-glycosylated form of ATF6 involved in the sensing of
the UPR pathway [51]. The ATF6 doublet, which appeared to
migrate slower in Wt-CFTR-expressing cells, was previously
described, and the non-glycosylated form of ATF6 was shown
to be generated by Tu treatment of the cells [52]. This doublet
was observed in our experiment (Fig. 2A).d in transfected A549 cells. A. Membrane proteins were biotinylated and CFTR
in is observed in the cell membrane of CFTR-expressing cells, its expression was
on-transfected A549 cells. B. Study of the cyclic AMP-induced I− efflux from
resent the mean (±S.E.M.) of the relative fluorescence (F/F0) from 10 randomly
he presence of I− (maximal fluorescence) measured initially in buffer (consisting
PES and 10 mM glucose). Following 20-min incubation, basal fluorescence was
M)/IBMX (100 μM). Intracellular SPQ was completely quenched by addition of
ve was obtained by the mean of at least 5 different experiments. The maximal
expressing ΔF508-CFTR, the fluorescence was decreased (middle curve). The
ted, lower curve). The slopes of the lines (a, b) correspond to the rate of SPQ
imulation (pcAMP). They were used to calculate the halide permeability (p) as the
s correspond to the rate of SPQ dequenching in NO3
− medium under baseline
±S.E. of three mock injected cells and three CFTR injected cells.
Fig. 2. Comparison of Grp78 and ATF6 expression in CFTR- andΔF508-CFTR-expressing cells. A. Grp78 and ATF6 were detected byWestern blotting in cell lysates.
Increased expression of the Grp78 was observed in ΔF508-CFTR-expressing cells when compared with CFTR-expressing cells (upper panel). The right panel shows
the result of a Western blot experiment performed to compare ATF6 expression. The 90 kDa form of ATF6 was increased in ΔF508-CFTR-expressing cells. In the
CFTR-expressing cells, a previously described doublet was seen (⁎). In the ΔF508-CFTR cells, the under-glycosylated form (⁎⁎) and the cleaved form of ATF6 were
observed. An example of actin detection (lower panel) shows that the loading was identical for both the CFTR and theΔF508-CFTR cells. B. Densitometric analysis of
the signal was performed. It was normalized by the total amount of loaded protein in each lane and statistical analysis was performed (n=12). Grp78 and ATF6
expression was significantly increased in ΔF508-CFTR cells. C. Detection of the cleaved ATF6 in the nuclei by Western blotting. Nuclei extracts were obtained from
transfected cells with the empty vector, the cDNA encoding CFTR and the cDNA encoding ΔF508-CFTR. These extracts together with the extract from non-
transfected cells were subjected to Western blotting. Cleaved ATF6 was only detected in the extract from ΔF508-CFTR cells.
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the translocation of ATF6 in the nuclei whenΔF508-CFTR was
expressed. The cleaved form of ATF6 was only detected in
ΔF508-CFTR-expressing cells (not shown). This result was
further confirmed by a biochemical assay. Nuclear preparations
were subjected to SDS/PAGE and ATF6 detection was per-
formed by Western blotting. As shown in Fig. 2C, the cleaved
form of ATF6 is only observed in the nuclei of the ΔF508-
CFTR protein-expressing cells.
3.3. Comparison of the protein expression of Grp78 and ATF6
between the Wt-CFTR and ΔF508-CFTR protein-expressing
A549 cells when an exogenous UPR stress is applied
Because CF involves inflammation and infections, which
both induce UPR, we studied the expression of Grp78 and ATF6
in both cell lines in the presence of the UPR inducers Tg and Tu.Tg is an ER calcium pump inhibitor which reduces the ER
luminal calcium concentration, and Tu is an N-linked glycosy-
lation inhibitor. Several experiments were performed in order to
determine the best UPR induction conditions to be used in our
cell type (not shown). Finally, non-transfected cells, Wt-CFTR-
and ΔF508-CFTR-expressing cells were incubated for 24 h in
the presence of 500 nMTg or 10 μg/ml Tu. As shown in Fig. 3A,
these conditions induced UPR since non-transfected cells
exhibited an increased expression of Grp78 and the cleaved
form of ATF6 under both Tg and Tu treatments. Wt-CFTR- and
ΔF508-CFTR-expressing cells exhibited an increased expres-
sion of Grp78 in the presence of Tg or Tu (Fig. 3A). The
quantitative analysis of Grp78 expression indicated that it was
significantly increased under Tg and Tu treatment in both cell
lines (Fig. 3B). ATF6 expression and cleaved ATF6 were ob-
served when Tg or Tu was used (Fig. 3A). Quantitative analysis
of ATF6 (50 kDa) expression indicated that it was significantly
Fig. 3. Comparison of Grp78 and ATF6 expression in the CFTR- and ΔF508-CFTR-expressing cells under normal conditions and under Tu and Tg conditions.
A. Example of a Western blot indicating that the Grp78 expression is increased in all cell lines when they are cultured in the presence of Tg or Tu (upper panel). The
middle panel represents Western blotting used to detect ATF6 expression in the same cell lines. Whereas the cleaved fragment of ATF6 is observed in ΔF508-CFTR-
expressing cells in the absence and presence of Tg or Tu treatment, in CFTR-expressing cells and in non-CFTR-expressing cells, this cleaved fragment is observed with
Tg and Tu. The lower panel shows an example of actin detection indicating that the loading was identical in all lanes. B. Quantitative analysis of Grp78 and ATF6
expression. They are significantly increased in CFTR-expressing cells under Tu or Tg conditions (left panel). Both Grp78 and ATF6 expressions are significantly
increased in ΔF508-CFTR cells under Tu or Tg conditions (right panel). C. Grp78 expression and ATF6 expression are not different between CFTR- and ΔF508-
CFTR-expressing cells in Tu conditions (left panel) and Tg conditions (right panel).
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the ΔF508-CFTR-expressing cells (Fig. 3B). Therefore we
concluded that both cell lines reacted under Tg or Tu treatment in
a UPR-related way. Once more we noticed that ATF6 was
cleaved inΔF508-CFTR-expressing cells without any treatment
(Fig. 3A).
Tg and Tu trigger UPR differently, so we performed a quan-
titative analysis in order to investigate a possible differentialresponse between Wt-CFTR- and ΔF508-CFTR-expressing
cells under Tg or Tu treatment. When the UPR stress was in-
duced by Tu, no significant difference was observed in GRP78
or ATF6 expression between Wt-CFTR- and ΔF508-CFTR-
expressing cells (Fig. 3C, right panel). The same result was
observed when Tg was used (Fig. 3C, left panel). We concluded
that the responses with Tg or Tu were not different between Wt-
CFTR- and ΔF508-CFTR-expressing cells.
Fig. 4. Comparison of Grp78 and ATF6 expression in the non-transfected cells (NT) and in the cells transfected with the empty pcDNA3.1 vector under normal
conditions and under Tu and Tg conditions. A. Example of a Western blot indicating that the Grp78 expression is increased in the NT cells and in the cells transfected
with the empty vector when they are cultured in the presence of Tg or Tu (upper panel). The lower panel represents an example of Western blot used to detect ATF6
expression in the same cell lines. Whereas the cleaved fragment of ATF6 is clearly observed in the presence of Tg or Tu, it is faint when cells are not treated. B. The
quantitative analysis of the Grp78 and the ATF6 expression indicates that there is no difference between non-transfected cells and cells transfected with the empty
plasmid.
Fig. 5. Analysis of the different forms of ATF6. 6% gel electrophoresis was
performed in order to visualize the 90 kDa form, the doublet and the un-
glycosylated forms of ATF6. Without any treatment, the unglycosylated form of
ATF6 is only observed in ΔF508-CFTR-expressing cells. Under Tg conditions,
the ATF6 doublet is observed in the non-transfected and CFTR-expressing cells
(middle panel). Under Tu conditions, the doublet is observed in the non-
transfected cells, and in CFTR- and ΔF508-CFTR-expressing cells (lower
panel). The unglycosylated form of ATF6 is only observed in theΔF508-CFTR-
expressing cells, whereas the doublet is not seen.
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between non-transfected cells and cells transfected with the
empty vector with and without Tg and Tu
The transfection with the cDNA encoding either Wt-CFTR
or ΔF508-CFTR could induce a cellular stress by itself.
Therefore, we compared Grp78 and ATF6 expression in cells
which were transfected with the empty vector with their ex-
pressions in non-transfected cells. As shown in Fig. 4A, no
difference was observed. When the cells were treated with either
Tg or Tu, the Grp78 and ATF6 expressions were identical in
both cell types. The results were confirmed by the quantitative
analysis of the blots (Fig. 4B).
3.5. Specific study of ATF6 expression in the absence and
presence of Tu and Tg
Using Western blotting, we studied the pattern of expression
of ATF6 in Wt-CFTR- and ΔF508-CFTR-expressing cells and
found that besides the fact that ATF6 expression was increased in
ΔF508-CFTR cells, several bands were observed on the films
(Fig. 5, upper panel). In order to study these bands after UPR
induction, less protein was loaded on a 6% gel, as previously
described [52], because with high protein loads the doublet
pattern could merge into a single band. After Tg treatment, the
non-transfected cells and the Wt-CFTR-expressing cells exhib-
ited a doublet which migrated slower than the non-glycosylatedform (Fig. 5, middle panel). After Tu treatment, non-transfected
cells, Wt-CFTR- and ΔF508-CFTR-expressing cells all exhib-
ited an additional band, close to the 90 kDa form of ATF6 (Fig. 5,
lower panel). This band was previously described and referred
to as a non-glycosylated form of ATF6 [41,52]. The ATF6
doublet was not seen in ΔF508-CFTR cells and instead the
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previously described [52]. The level of the 90 kDa band was
increased when the UPR induction was performed over a long
period of time [52].
3.6. Study of the interaction between Grp78 and ATF6
In unstressed cells, Grp78 binds to the luminal domain of
ATF6, sequestering ATF6 in the ER and preventing its acti-
vation [53]. When UPR is triggered, ATF6 is released from
Grp78. Grp78 also binds to newly synthesized proteins and
more permanently to under-glycosylated and misfolded proteins
[54]. The formation and dissociation of the Grp78/ATF6 com-
plex is a key event in UPR triggering. Nevertheless, the com-
plex dissociation is unclear and two models have been proposed
[44,53]. The first assumes that unfolded proteins compete with
Grp78 for ATF6 binding. The second assumes that the Grp78–
ATF6 binding is stable and is actively dissociated by a signal
from the UPR. Therefore, we compared the presence of Grp78
and ATF6 in immunoprecipitates from Wt-CFTR- and ΔF508-
CFTR-expressing cells. Magnetic beads were covered with an
anti-Grp78 antibody and further incubated with proteins from
Wt-CFTR- or ΔF508-CFTR-expressing cells. The presence of
ATF6 in the immunoprecipitated complex was investigated. As
shown in Fig. 6 (upper panel), ATF6 is bound to Grp78 in Wt-
CFTR and ΔF508-CFTR cells. This result was also observed
when cells were treated with Tg or Tu. More ATF6 was bound
when ΔF508-CFTR was expressed. The opposite experiment
was performed. The anti-ATF6 was linked to the beads and
Grp78 was detected (Fig. 6, lower panel). Once more we found
that the interaction was stable when UPRwas triggered, showing
that the complex is stable as previously described [53]. More
Grp78 was bound in ΔF508-CFTR cells. Because the dissocia-
tion of the complex is not due to the unfolded ΔF508-CFTR,
since it was previously shown that CFTR does not interact with
Grp78, the maintained ATF6 association could be due to the
under-glycosylated form of ATF6 [55,56]. From these experi-
ments we concluded that the Grp78/ATF6 complex in ΔF508-
CFTR cells belongs to the previously described stable model
[53].Fig. 6. Study of the Grp78/ATF6 complex by co-immunoprecipitation. The Grp78/A
panel) or anti-ATF6 (lower panel) antibodies. They were incubated with protein ext
without Tg or Tu. The complex was analysed by Western blotting using a first antib
indicate that the Grp78/ATF6 complex is stable in all conditions. Negative controls w
performed with the beads covered with the antibody used in Western blotting.3.7. Study of the cAMP-dependent halide flux through
ΔF508-CFTR when Grp78 expression is decreased
Under unstressed conditions, Grp78 binds to the luminal
domain of IRE1 and PERK to maintain them within the ER and
prevent their activation [39,43]. Grp78 is described as the main
UPR sensor which activates UPR transducers ATF6, IRE1 and
PERK by releasing them [54].
Due to the key involvement of Grp78 in UPR triggering, we
investigated its possible involvement in the cAMP-dependent
halide flux through Wt-CFTR in ΔF508-CFTR-expressing cells.
For this purpose we used the siRNA technology in order to
decrease its expression and disrupt UPR triggering in the cells and
investigate whether this decreased expression could release the
ΔF508-CFTR from the ER and restore some cAMP-dependent
halide flux in ΔF508-CFTR cells. As shown in Fig. 7A, the
lowest expression of Grp78 was obtained 48 h after the trans-
fection of the specific siRNA (−80%), whereas no modification
was observed at the corresponding time point when an irrelevant
siRNA was used. Actin expression was not modified by the
siRNA (Fig. 7B). As shown in Fig. 7C, the decreased Grp78
expression did not modify the level of the cAMP-dependent
halide flux in the cells. The irrelevant siRNA had no effect upon
this function.
3.8. Study of the cAMP-dependent halide flux through
ΔF508-CFTR protein when ATF6 expression is decreased
Because ATF6 is the main signalling regulator in UPR,
we investigated its role in the cAMP-dependent halide flux
via ΔF508-CFTR [39–44]. As shown in Fig. 8A, ATF6 ex-
pression was decreased 48 h after siRNA transfection. At
this time point, actin expression was not altered (Fig. 8B).
The cAMP-dependent halide flux through ΔF508-CFTR was
studied when ATF6 expression was at a minimum. As shown
in Fig. 8C, the cAMP-dependent halide flux through ΔF508-
CFTR was significantly increased when ATF6 expression
was inhibited.
UPR may be triggered by inflammation and infection.
Therefore, we studied the cAMP-dependent halide flux throughTF6 complex was studied by the use of beads covered with anti-Grp78 (upper
racts from non-transfected, CFTR- and ΔF508-CFTR-expressing cells, with or
ody directed against ATF6 (upper panel) or Grp78 (lower panel). Both images
ere performed with an irrelevant antibody on the beads. Positive controls were
Fig. 7. Analysis of the effect of the specific siRNA directed against Grp78 upon
the cAMP-dependent halide flux throughΔF508-CFTR. A. Example of Western
blot performed to detect Grp78 inΔF508-CFTR-expressing cells. The left panel
represents Grp78 detection when cells were transfected with an irrelevant
siRNA, and the right panel represents Grp78 detection in the presence of the
specific siRNA. Histograms represent the corresponding quantification of
Grp78. Whereas the irrelevant siRNA had no effect upon Grp78 expression, the
specific siRNA significantly decreased expression, 48 h after the transfection.
B. Western blot performed to assess actin expression in the presence of siRNA,
showing that the amount of protein was the same at the different transfection
times and that actin was not altered by siRNA. C. SPQ experiments were
performed usingΔF508-CFTR-expressing cells without siRNA, in the presence
of the irrelevant siRNA and in the presence of the specific siRNA directed
against Grp78. No significant difference was observed between the cell types.
The membrane permeability to halides (p) was determined as the rate of SPQ
dequenching upon perfusion with NO3
− medium [47]. The data represent the
mean±S.E.M. (n=5).
Fig. 8. Analysis of the effect of the specific siRNA directed against ATF6 upon the
cAMP-dependent halide flux through ΔF508-CFTR. A. Example of Western blot
performed to detect ATF6 inΔF508-CFTR-expressing cells. The left panel rpresents
ATF6 detection when cells were transfected with an irrelevant siRNA, and the right
panel represents ATF6 expression in the presence of the specific siRNA. Histograms
represent the corresponding quantification of ATF6. Whereas the irrelevant siRNA
had no effect upon ATF6 expression, the specific siRNA significantly decreased
expression 48 h after the transfection. B. Western blot performed to assess actin
expression in the presence of siRNA, showing that the amount of protein was the
same at the different transfection times and that actin was not altered by siRNA.
C. SPQ experiments were performed using ΔF508-CFTR-expressing cells without
siRNA, in the presence of the irrelevant siRNA and in the presence of the specific
siRNA directed against ATF6. The membrane permeability to halides (p) was
determined as the rate of SPQ dequenching upon perfusion with NO3
−medium [47].
A significant increase in cAMP-dependent halide flux through ΔF508-CFTR was
observed (the data represent the mean±S.E.M., n=6, ⁎⁎: pb0.01).
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applied to the Wt-CFTR cells, halide flux was decreased,
with a greater effect for Tg (Fig. 9A). Surprisingly, neither
Tu nor Tg decreased the residual cAMP-dependent halide
flux in the ΔF508-CFTR-expressing cells. When ΔF508-CFTR
cells, in which ATF6 expression was decreased, were treated
with Tg or Tu, cAMP-dependent halide flux was increased
(Fig. 9B and C).3.9. Study of the cell surface expression of the ΔF508-CFTR
protein when ATF6 is decreased
To explain the increased cAMP-dependent halide flux through
ΔF508-CFTR when ATF6 expression is decreased, we studied
1245M. Kerbiriou et al. / Biochimica et Biophysica Acta 1772 (2007) 1236–1249the membrane expression of ΔF508-CFTR. Membrane proteins
were biotinylated, purified and resolved by SDS/PAGE. The
presence of the CFTR protein was assessed by Western blotting.
As shown in Fig. 10, the presence of the ΔF508-CFTR protein
in the membrane of the cells was increased when ATF6 expres-
sion was decreased. Nevertheless, its level was lower than in theFig. 9. Study of cAMP-dependent halide flux through ΔF508-CFTR by SPQ.
A. Histograms represent the halide permeability through CFTR and ΔF508-
CFTR in the absence or presence of Tg or Tu (n=5). p was calculated as
previously described [47]. Whereas Cl− channel activity is decreased when UPR
is triggered, it is not affected inΔF508-CFTR cells. B. Histograms represent the
halide permeability through ΔF508-CFTR in the absence or presence of the
siRNA directed against ATF6 under Tg treatment (n=6). The results indicate
that the inhibition of ATF6 increased halide permeability throughΔF508-CFTR.
C. The same experiment was performed as in B, but Tg was replaced by Tu. The
cAMP-dependent halide flux through ΔF508-CFTR was increased when ATF6
expression was decreased (n=6).Wt-CFTR-expressing cells. The control siRNA (irrelevant) was
ineffective.
4. Discussion
In the most common genetic form of CF (ΔF508/ΔF508),
incorrectly folded CFTR is retained in the ER and partially
degraded. Because accumulation of unfolded or misfolded pro-
tein in the ER induces an adaptive response called UPR, we
investigated a possible involvement of this response in CF. To
date, the UPR triggering in CF has been little studied [57,58].
One master regulator (Grp78/BiP) and three classes of UPR
transducers (IRE1, PERK and ATF6) have been shown to be
involved in UPR [54]. In addition, XBP1 was shown to par-
ticipate in UPR. The present study focused on the UPR re-
gulator Grp78 and the UPR transducer ATF6 in a ΔF508-
CFTR-expressing cell model. Grp78 is an ER-resident protein
whose synthesis is enhanced in cells that are stimulated by
various environmental and physiological stress conditions that
perturb ER function and homeostasis [43]. In unstressed cells,
Grp78 binds to the UPR transducer ATF6, which is maintained
in an inactive form. Upon ER stress, Grp78 releases ATF6
which is translocated from the ER to the Golgi where it is
cleaved by the proteases S1P and S2P [50]. The cleaved part of
ATF6 enters the nucleus where it functions as a transcription
factor for the UPR target genes, including Grp78 [40,41].
Although the use of transfected cells is widespread, we first
showed that our cellular model is usable in studying the rela-
tionship between ΔF508-CFTR protein expression and UPR.
Most of the ΔF508 protein was retained in the ER whereas the
Wt-CFTR was present in the cell membranes. This localization
was correlated with biochemical assays and the decreased cAMP-
dependent halide flux through CFTR, as previously reported
in the A549 transfected cells [46]. Grp78 protein expression
was increased in the ΔF508-CFTR-expressing cells, which is a
hallmark of UPR [39,42,43,49,54]. Besides this increased ex-
pression of Grp78, the cleaved form of ATF6 was observed. This
represented further evidence of UPR triggering when ΔF508-
CFTR is expressed [40,41,50–52]. Conversely, a recent paper by
Nanua et al. indicates that in cultured cells of airway segments
from three CF patients homozygous for the ΔF508 mutation,
Grp78 expression was not increased at the mRNA or protein level
[57]. In the same paper, the electrophoretic mobility of cleaved
and uncleaved ATF6 was studied in the cells from these three
patients. The immunoblots showed a decreased abundance of the
full-length ATF6. This could be explained by the appearance of
the cleaved form of ATF6. The observed discrepancy with the
present results regarding Grp78 and ATF6 expression may be due
to the cell type used. Furthermore, the results obtained for Grp78
and ATF6 mRNA expression in the cells from the three patients
were normalized by glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). We normalized our protein expression by the total
amount of protein loaded on the gels, since the UPR pathway is
not completely known. In the study using cells from patients,
protein expression was normalized using actin. Nevertheless,
GAPDH expression is modulated under various stress cell con-
ditions [60] such as hypoxia [61,62] and dysregulation of growth
Fig. 10. Increased membrane localization of the CFTR protein in the ΔF508-CFTR-expressing cells in the presence of the specific siRNA directed against ATF6.
Membrane proteins of the Wt-CFTR, the ΔF508-CFTR and the non-transfected cells were biotinylated. Biotinylated proteins were purified, submitted to SDS/PAGE
(7.5% gel electrophoresis) and CFTR was detected by Western blotting. The CFTR protein (mature band, 170 kDa) is observed in the cell membrane of CFTR-
expressing cells. Whereas its expression was lower in the ΔF508-CFTR-expressing cells, it was increased in the presence of the siRNA directed against ATF6. No
CFTR protein was detected in the non-transfected A549 cells although the cells were transfected with the specific siRNA. The control was performed with the
irrelevant siRNA.
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volved in other functions apart from basal cell metabolism, which
may modify its level of expression in stressed tissues [64].
Furthermore, GAPDH has been related to a disease involving
UPR [65] and some studies point to glucose metabolism alte-
rations as a cause of clinical deterioration in patients with CF
[66,67]. Therefore, we believe that the use of the GAPDH to
normalize the mRNA levels of proteins involved in the UPR
pathway may lead to the observed discrepancy. Concerning the
actin normalization, it was previously shown in cells treated with
Tg that the increased Grp78 mRNA level was associated with
decreased expression of actin mRNA [67]. Furthermore, renal
proximal tubule epithelial cells (LLC-PK1) treated with a pros-
taglandin analogue exhibited increased Grp78 and actin expres-
sion, showing a direct link in the expression of both proteins [68].
Therefore, actin normalization of protein expression could also
explain the discrepancy. More importantly, Grp78 regulation may
be involved in the apparent discrepancy between ourwork and the
data of Nanua et al. It was previously shown that the tran-
scriptional regulation and translational regulation of Grp78 are
independent events and that a rapid translational response permits
the cells to adapt to small perturbations without a transcriptional
response [69]. Due to the sensor properties of Grp78, we hy-
pothesize that the stress level in the cells of Nanua et al. was not
reached, whereas in our transfected cells the level of ΔF508-
CFTR was sufficient to induce Grp78 activation. This latter point
ismore likely the explanation for the observed discrepancy, which
should be correlated with another discrepancy: whereas protea-
some inhibition, which is known to induce UPR, had no effect on
CFTR protein abundance, a recent study shows that ER stress
caused by brefeldin A or Tu results in an increase in spliced XBP1
levels and a decrease in endogenous CFTR transcript levels very
similar to that observed with proteasome inhibition [59]. The use
of different cell types expressing endogenous or transfected
CFTR could induce various UPR pathways. Indeed, Nanua ex-
periments were performed in primary cell culture from three
patients. Therefore, these cells may have been exposed to in-
flammation and infections that are present in CF. Furthermore,
patients may have been under drug treatments which can modify
the UPR pathway (for review, [70]). Furthermore, we used non-
polarized epithelial cells in which the involved pathways may bedifferent. The A549 cells were used because they are from human
airways and do not express the CFTR protein [71] whereas the
Wt-CFTR and ΔF508-CFTR expression, localization and func-
tion were previously described in these cells after transfection
[72,46]. A549 cells were also used because they were previously
characterized regarding GRP78 [73]. Furthermore, they have
recently been shown to elicit a classical UPR pathway in which
translation attenuation, phosphorylation of eIF2alpha, splicing of
XBP-1 and nuclear translocation of ATF6 were observed [74].
Nevertheless, A549 cells are not polarized and may present a
different trafficking process when compared to polarized cells.
Polarized monolayers of human airway epithelial cells are the
desirable model to study CFTR traffic but primary cell systems
causes major limitations to the feasibility of the experiments since
they are difficult to maintain in culture whereas we needed to
perform culture for a long period of time in order to perform drug
treatments. Moreover, their CFTR expression levels have been
observed to decrease with increasing number of passages (for
review, [75]). Finally, the present results are focused upon UPR
and to a less extent upon CFTR trafficking sinceΔF508-CFTR is
retained in the ER.
Whereas Nanua et al. found that only a subset of elements of
UPR is activated in ΔF508/ΔF508 CF cells, we concluded that
in our cell model the Grp78 sensor and the AFT6 transducer
were activated. These activations cannot be due to over-expres-
sion of recombinant Wt-CFTR since this does not activate UPR
[58]. Furthermore, we show here that the transfection by itself
does not induce the UPR pathway. Nevertheless, our results do
not rule out the previously described atypical UPR in CF cells
[57].
In the present paper, we show a differential involvement of
Grp78 and ATF6 when the mutated CFTR protein is expressed.
This is likely due to a different electrophoretic form of ATF6 in
the ΔF508-CFTR cells, to the absence of Grp78-CFTR asso-
ciation, and to the stable Grp78/ATF6 complex in UPR, which
is confirmed in the present study [53]. The unglycosylated form
of ATF6 was previously studied. It was shown to trigger the
UPR pathway by itself and to exhibit a reduced interaction with
ER chaperones. It titrates away Grp78, releasing UPR signalling
molecules and the full-length ATF6, which can then be cleaved.
Furthermore, this form of ATF6 is transported faster to the
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to triggering of the UPR pathway [51]. Therefore, the presence
of this form of ATF6 in the ΔF508-CFTR-expressing cells
could explain why the upregulation of Grp78 does not inhibit
UPR. Our results indicate that UPR triggering in the ΔF508-
CFTR cells also depends on the inducer even though both Wt-
CFTR and ΔF508-CFTR cells react to the stress. This point is
of interest due to the various potential inducers encountered in
CF and should be correlated with the described positive effect of
Tg on ΔF508-CFTR function [76]. Short treatment of the cells
with Tg restores some ΔF508-CFTR function [76], whereas
longer treatment induces UPR. This indicates that a threshold
has to be reached to trigger UPR. Finally, we show that the
downregulation of ATF6 leads to increased cAMP-dependent
halide flux through CFTR due to its increased expression in the
cell membrane. This can be explained by the decreased protein
expression observed when UPR is triggered. By altering ATF6
expression, we decreased UPR triggering leading to arrest of the
negative effect upon ΔF508-CFTR expression. Furthermore,
ATF6 activates the ER stress response element, which induces
GRP gene transcription [77]. Among GRP, calreticulin has
recently been shown to downregulate the expression and mem-
brane localization of CFTR [78,79]. Therefore, the increased
cAMP-dependent halide flux through ΔF508-CFTR when
ATF6 expression is decreased can easily be explained by a
decreased retention of the protein in the ER via decreased
calreticulin expression.
The present results are of major importance because UPR is
followed by significant changes in genomic CFTR mRNA and
because endogenous CFTR biogenesis is regulated by UPR
[58].
In conclusion, we show for the first time a specific in-
volvement of ATF6 in ΔF508-CFTR cells and demonstrate that
its decreased expression leads to restored cAMP-dependent
halide flux in cells. We suggest that in CF, whereas the in-
volvement of Grp78 is minor, because it does not interact with
CFTR [53], ATF6 may be of a great importance because its
decreased expression induces an increased membrane localiza-
tion of CFTR. Furthermore, the unglycosylated form of ATF6
seems to be the main UPR effector in CF. Therefore, we provide
new information regarding CF pathophysiology and open up a
new field in the search for therapeutics.
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